Effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, on monoamine system in mice and rats

Journal of Pharmacological Sciences
Rui XueYou-Zhi Zhang

Abstract

Our previous study indicated that 071031B, a novel potential serotonin and norepinephrine reuptake inhibitor, showed robust antidepressant activity in multiple depression models, and could simultaneously inhibit 5-HT and NE reuptake in vitro. The present study was to evaluate the effects of 071031B on monoamine system in vivo, by using pharmacological models, including 5-HTP induced head-twitch test, yohimbine toxicity potentiation test, and reserpine induced hypothermia test, and determining monoamine transmitter levels in reserpine induced monoamine depletion model or chronic unpredictable stress (CUS) model. Results in pharmacological models indicated that acute administration of 071031B at 5-20 mg/kg significantly enhanced 5-HTP induced head-twitch behavior, potentiated yohimbine induced lethal rate, and reversed reserpine induced hypothermia. Further monoamine assays demonstrated that acute or chronic administration of 071031B at 10 or 20 mg/kg increased 5-HT and/or NE levels in various brain regions in reserpine or CUS induced monoamine depletion models, respectively, without effect on DA and its metabolites. Our results revealed that 071031B produces potent inhibition of 5-HT and NE reuptake in vivo.

References

Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R J KatzB J Carroll
May 14, 1999·British Journal of Pharmacology·E RivasJ A Fontenla
Feb 1, 1963·British Journal of Pharmacology and Chemotherapy·S J CORNEB T WARNER
Nov 24, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Anders D WestanmoRobert Haight
Mar 28, 2008·Pharmacology, Biochemistry, and Behavior·Lei AnYun-Feng Li
May 16, 2009·Journal of Pharmacological Sciences·Sandra VezmarMilena Pokrajac
Jul 4, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rui XueYou-Zhi Zhang
Apr 11, 2013·Neuroscience Letters·Rui XueYun-Feng Li
Apr 15, 2014·British Journal of Pharmacology·B Guardiola-LemaitreE Mocaër

❮ Previous
Next ❯

Citations

Mar 13, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Zeng-liang JinYu Tang
Jan 23, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Qi ShenZhu Luo
Aug 3, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Xiao-Le WangYi Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.